SE447871B - Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar - Google Patents

Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar

Info

Publication number
SE447871B
SE447871B SE8400723A SE8400723A SE447871B SE 447871 B SE447871 B SE 447871B SE 8400723 A SE8400723 A SE 8400723A SE 8400723 A SE8400723 A SE 8400723A SE 447871 B SE447871 B SE 447871B
Authority
SE
Sweden
Prior art keywords
pellets
pinacidil
pharmaceutical composition
eudragit
content
Prior art date
Application number
SE8400723A
Other languages
English (en)
Swedish (sv)
Other versions
SE8400723D0 (sv
SE8400723L (sv
Inventor
E J Didriksen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of SE8400723D0 publication Critical patent/SE8400723D0/xx
Publication of SE8400723L publication Critical patent/SE8400723L/
Publication of SE447871B publication Critical patent/SE447871B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE8400723A 1983-02-11 1984-02-10 Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar SE447871B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK0589/83A DK58983D0 (da) 1983-02-11 1983-02-11 Farmaceutisk praeparat

Publications (3)

Publication Number Publication Date
SE8400723D0 SE8400723D0 (sv) 1984-02-10
SE8400723L SE8400723L (sv) 1984-08-12
SE447871B true SE447871B (sv) 1986-12-22

Family

ID=8095276

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8400723A SE447871B (sv) 1983-02-11 1984-02-10 Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar

Country Status (15)

Country Link
US (1) US4600577A (member.php)
JP (1) JPS59155312A (member.php)
BE (1) BE898882A (member.php)
DE (1) DE3404595A1 (member.php)
DK (1) DK58983D0 (member.php)
ES (1) ES8608490A1 (member.php)
FR (1) FR2540727B1 (member.php)
GB (1) GB2134785B (member.php)
IE (1) IE56604B1 (member.php)
IT (1) IT1196682B (member.php)
NL (1) NL8400430A (member.php)
NZ (1) NZ207010A (member.php)
PH (1) PH21734A (member.php)
SE (1) SE447871B (member.php)
ZA (1) ZA84856B (member.php)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US5286494A (en) * 1986-07-02 1994-02-15 Schering Aktiengesellschaft Medicinal agents with sustained action
US4861598A (en) * 1986-07-18 1989-08-29 Euroceltique, S.A. Controlled release bases for pharmaceuticals
EP0579260A1 (en) * 1987-07-07 1994-01-19 Beecham Group Plc Use of a vasodilator for the treatment of pulmonary hypertension and/or right heart failure-related conditions
US5009894A (en) * 1988-03-07 1991-04-23 Baker Cummins Pharmaceuticals, Inc. Arrangement for and method of administering a pharmaceutical preparation
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
US5328697A (en) * 1992-02-10 1994-07-12 Mallinckrodt Veterinary, Inc. Compositions and processes for the sustained release of drugs
JP2002535353A (ja) 1999-01-29 2002-10-22 ロザン ファルマ ゲゼルシャフトミットベシュレンクテルハフツンク 医薬品組成物
US6210716B1 (en) * 1999-02-26 2001-04-03 Andrx Pharmaceuticals, Inc. Controlled release bupropion formulation
WO2000067754A1 (en) 1999-05-12 2000-11-16 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
IL151150A0 (en) * 2001-01-31 2003-04-10 Roehm Gmbh Multiparticulate drug form comprising at least two differently coated pellet forms
AU2005264864B2 (en) 2004-06-16 2011-08-11 Takeda Pharmaceutical Company Limited Multiple PPI dosage form
BRPI0818286A2 (pt) 2007-10-12 2020-08-11 Takeda Pharmaceuticals North America, Inc. métodos de tratamento de distúrbios gastrointestinais independente da ingestão de alimento.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
JPS54129115A (en) * 1978-03-31 1979-10-06 Yasuyo Miyauchi Long acting amoxycilin preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
FR2477015A1 (fr) * 1980-03-03 1981-09-04 Fabre Sa Pierre Composition pharmaceutique a base d'un alcaloide de l'ergot de seigle, a activite regulatrice sur le tonus vasculaire
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
EP0052075A1 (de) * 1980-11-12 1982-05-19 Ciba-Geigy Ag Körnige Arzneimittel-Retardform
DE3127984A1 (de) * 1981-07-15 1983-02-03 Klinge Pharma GmbH, 8000 München Orale arzneimittel fuer die kariesprophylaxe

Also Published As

Publication number Publication date
SE8400723D0 (sv) 1984-02-10
IT1196682B (it) 1988-11-25
PH21734A (en) 1988-02-10
BE898882A (fr) 1984-08-10
JPH0451528B2 (member.php) 1992-08-19
GB8403572D0 (en) 1984-03-14
GB2134785A (en) 1984-08-22
SE8400723L (sv) 1984-08-12
US4600577A (en) 1986-07-15
ZA84856B (en) 1984-09-26
ES8608490A1 (es) 1986-06-16
IT8467131A0 (it) 1984-02-13
IE840146L (en) 1984-08-11
GB2134785B (en) 1986-07-02
NL8400430A (nl) 1984-09-03
FR2540727B1 (fr) 1987-01-23
DE3404595A1 (de) 1984-08-16
DE3404595C2 (member.php) 1993-04-29
JPS59155312A (ja) 1984-09-04
IE56604B1 (en) 1991-10-09
IT8467131A1 (it) 1985-08-13
DK58983D0 (da) 1983-02-11
FR2540727A1 (fr) 1984-08-17
ES529660A0 (es) 1986-06-16
NZ207010A (en) 1987-06-30

Similar Documents

Publication Publication Date Title
US4772475A (en) Controlled-release multiple units pharmaceutical formulation
EP0519870B1 (de) Neue orale Diclofenaczubereitung
FI78835C (fi) Foerfarande foer framstaellning av en ny dipyridamol-retardform.
EP0431877B1 (en) Cimetidine pharmaceutical compositions
US4983401A (en) Sustained release pharmaceutical preparations having pH controlled membrane coatings
AU680891C (en) Controlled release preparation containing a salt of morphine
DE60020551T2 (de) Orale formulierung zur verabreichung in den ileum enthaltend einen hemmstoff des ileum-gallensäuretransports
KR101873075B1 (ko) 하나 이상의 알긴산 염을 포함하는 위 내성 제약 또는 건강기능식품 제제
BG65398B1 (bg) Ентерично покрит фармацевтичен състав и метод за получаване
SE457505B (sv) Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
SK9899A3 (en) Tramadol multiple unit formulations
HUT75683A (en) Delayed, sustained-release pharmaceutica preparations
DE3024858A1 (de) Anhaltend freigebende pharmazeutische zubereitung eines festen medikamentmaterials
SE447871B (sv) Farmaceutisk komposition med lang utsondringstid innefattande pinacidil i minst tva olika typer av pelletar
CS268819B2 (en) Method of particles production with effective substance's controlled loosening
DE2336218A1 (de) Neue orale arzneiform und verfahren zu ihrer herstellung
SE455836B (sv) Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
WO2003051343A1 (en) Pulsatile release histamine h2 antagonist dosage forms
KR20180015245A (ko) 에탄올의 영향에 대한 내성을 갖는 약학적 또는 영양 보조 식품적 조성물
CA2000932C (en) Oral pharmaceutical controlled release multiple unit dosage form
JPS6248618A (ja) 徐放性製剤およびその製造法
KR20110102339A (ko) 고정용량 복합제용 탐술로신 펠렛
JPS58116414A (ja) ニカルジピン持続性製剤用球形顆粒およびその製造法
WO2007117110A2 (en) Sustained-release pellets containing tamsulosin hydrochloride and processes for preparing the same
WO2005053659A1 (en) An improved pharmaceutical formulation containing tamsulosin salt and a process for its preparation

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8400723-6

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8400723-6

Format of ref document f/p: F